LABGENIUS
LabGenius, a pioneer in the use of machine learning (ML) for antibody-based drug discovery, today announced the appointment of Leonard Wossnig Ph.D. as Chief Technology Officer (CTO). In this role, Leonard will lead a team of Data Scientists, Software Engineers, and Automation Experts to further enhance LabGenius’ data-driven platform capabilities.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20221115005063/en/
Dr. Leonard Wossnig, LabGenius CTO (Photo: Business Wire)
“Leonard is a brilliant addition to our team,” says LabGenius’ CEO and Founder, Dr. James Field. “His proven track record of implementing cutting-edge machine learning solutions for drug discovery programmes will supercharge our ability to deliver across multiple discovery projects.”
In 2018, Leonard co-founded Rahko, a leading quantum machine learning company whose technology platform combined computational chemistry, machine learning and quantum computing to drive a better understanding of drug behaviour. During his time as CEO, Leonard directed Rahko’s commercial and scientific strategy, which aimed to remove bottlenecks in drug discovery by applying quantum machine learning models to the identification and optimisation of potential drug candidates. Earlier this year, Rahko was acquired by Odyssey Therapeutics, where, as VP of AI, Leonard led a team of machine learning experts to develop a computational platform for generative drug design in the areas of cancer and inflammation.
Commenting on his appointment, Leonard said: “The ML-driven antibody-based platform that the team at LabGenius has built presents an opportunity to revolutionise today’s approach to drug discovery. Through the development of bespoke automated pipelines, the team is able to generate high-quality data at scale — this is a crucial precursor to the effective use of machine learning. With these solid foundations in place, I am excited to apply my experiences to help unlock the vast potential that computational methods have to accelerate the discovery of better medicines.”
Dr. Edwin Moses, LabGenius’ Chairman commented that “Leonard's appointment reinforces LabGenius’ commitment to technical excellence. His expertise in generative molecule design, paired with LabGenius’ cutting-edge drug discovery platform, is an excellent combination, which will further accelerate the company’s ability to discover uniquely powerful protein-based therapeutics.”
– end –
About LabGenius
Headquartered in London, LabGenius is a leading machine learning-driven protein engineering company. The company’s core technology platform, EVA™, enables the rapid discovery of novel therapeutic antibodies. LabGenius’ highly multidisciplinary team brings together the very best minds from the fields of computer science, robotic automation and synthetic biology.
For more information, please visit www.labgeni.us, or connect on Twitter, LinkedIn and Medium.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20221115005063/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Celonis Unveils Platform Innovations to Power the AI-Driven, Composable Enterprise4.11.2025 11:00:00 CET | Press release
Celonis, a global leader in Process Intelligence, today at Celosphere 2025 announced major platform innovations that power enterprise AI to reinvent and continuously improve business operations. Daniel Brown, Chief Product Officer at Celonis, emphasized the need for a structured approach to agentic AI. “To truly operationalize AI, you need to identify the right use cases, redesign your business processes, and orchestrate the agents alongside your people and existing systems," Brown said. "Our enhanced capabilities empower our customers and their partners to build AI solutions that lift their operations to unprecedented levels of efficiency and agility.” The Celonis Process Intelligence Platform extracts raw data from systems, applications and devices within and across enterprises. It enriches this data with customers’ unique business context to create a living digital twin of operations—the Process Intelligence Graph. On top of the Graph, the Process Intelligence Platform provides the
Celonis Partners with Databricks to Power Enterprise AI that Continuously Improves Business Operations4.11.2025 11:00:00 CET | Press release
Direct live access to data gives organizations the process-centric context they need to make AI work in the enterprise Celonis, a global leader in Process Intelligence, today announced a partnership with Databricks, the Data and AI company, to provide customers with a seamless, powerful pathway to operationalize AI. The integration leverages Delta Sharing to directly connect the Celonis Process Intelligence Platform with the Databricks Data Intelligence Platform. Delta Sharing is Databricks’ open source approach that enables customers to share live data across platforms, clouds and regions with strong security and governance. This bi-directional integration, powered by Delta Sharing, eliminates the need to move or copy data between the two platforms. It breaks down data silos, reduces data copies, limits synchronization errors, enhances security, and simplifies data governance. With data and process intelligence flowing freely between the two platforms, customers get a continuous learn
Celonis Customers Drive Tangible Business Outcomes with Enterprise AI powered by Process Intelligence4.11.2025 11:00:00 CET | Press release
At Celosphere 2025, Celonis highlighted that 120 “Value Champions” have realized more than $10 million in value each and $8.1 billion in total. Celonis, a global leader in Process Intelligence, today at Celosphere 2025 showcased how leading companies from around the world are reinventing their operations and generating real business results using Enterprise AI, powered by Process Intelligence (PI). "We see so many organizations struggling to get a return on their AI investments,” said Alex Rinke, Celonis co-CEO and co-founder, during his keynote address. “This often happens because they’re thinking about ‘Enterprise AI’ as a technology. In reality, it’s the strategic discipline of infusing AI into every part of their operations. This is what Celonis and our partners help our customers do. We give their AI the context it needs. We guide them to deploy it in the right places. And, we enable them to make it work with everything else they’re doing.” Customer momentum driven by Celonis’ ope
ExtraHop® Expands Presence in EMEA to Meet Enterprise Demand for NDR4.11.2025 10:00:00 CET | Press release
Extends strategic partnership with Ignition Technology to fight modern cyber threats in Northern European markets ExtraHop®, a leader in modern network detection and response (NDR), today announced its expansion into the Nordics and Benelux markets. This strategic move strengthens the company's European footprint on the heels of a period of significant enterprise growth. Following a strong 2024, in which ExtraHop more than doubled its sales to Global 2000 customers in EMEA, the company is bringing its proven momentum to two of the continent's most dynamic markets housing global enterprise headquarters and a thriving ecosystem of world-class tech innovators. To introduce its industry-leading NDR platform to the Nordics and Benelux regions, ExtraHop is extending its distribution agreement with Ignition Technology, a specialist in SaaS-based cybersecurity. Building upon the partnership’s success in the UK and France, the expansion will address growing demand in northern and western Europe
STV to Deploy Post-Quantum’s Secure Communications Platform, Forms Strategic Cooperation to Deliver Next-Generation Security4.11.2025 10:00:00 CET | Press release
STV Group a.s. (“STV”), one of the world’s fastest-growing defence innovators, has signed a multi-year licence agreement to use Post-Quantum’s groundbreaking quantum-safe communications platform and signed a Strategic Cooperation Agreement to accelerate deployment across Europe, NATO, and global defence markets. With quantum computing threatening to render traditional encryption obsolete, the move positions STV at the forefront of the cybersecurity revolution - arming governments, defence forces, and enterprises with next-generation resilience against “Harvest Now, Decrypt Later” attacks. By fusing Post-Quantum’s NATO-tested modular platform with its own world-class defence solutions, STV is setting a new global benchmark for secure communications and digital trust. Together, the two companies are delivering the most advanced, future-proof systems to protect sensitive data and mission-critical operations - ensuring that even in the quantum era, allied communications remain impenetrable
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom